Background: Despite potential harm that can result from polypharmacy, real-world data on
polypharmacy in the setting of heart failure (HF) are limited. We sought to address this …

Background: Polypharmacy is associated with a poor prognosis in the elderly, however,
information on the association of polypharmacy with cardiovascular outcomes in heart …

Background Polypharmacy continues to be a topic of concern among older adults and puts
patients at increased risk of potential drug-drug interactions (DDIs) and negative health …

Polypharmacy and heart failure are becoming increasingly common due to an ageing
population and the rise of multimorbidity. Treating heart failure necessitates prescribing of …

In heart failure (HF), the progressive use of multiple drugs and a complex therapeutic
regimen is common and is recommended by international guidelines. With HF being a …

Background Polypharmacy—the concurrent prescription of multiple medications—is a
salient consideration in the care of older patients with heart failure. Little is known, however …

Aim To synthesise current study findings on the diseases and the corresponding
medications that are potentially associated with polypharmacy in community‐dwelling older …

Background—Guidelines for heart failure (HF) recommend prescription of guideline-directed
medical therapy before hospital discharge; some of these therapies are included in publicly …

Introduction: Polypharmacy, defined as the use of multiple drugs or more than are medically
necessary, is a growing concern for older adults. MEDLINE and EMBASE databases were …

Background Older people are a growing population. They live longer, but often have
multiple chronic diseases. As a consequence, they are taking many different kind of …